RN7SL146P

Across TCGA pan-cancer cohorts, RN7SL146P RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of RN7SL146P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RN7SL146P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL146P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

COAD, HNSC, and BLCA are the cancer types where RN7SL146P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL146P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.310	<.001	8	view →
HNSC	Male	All	+0.135	.001	8	view →
BLCA	Female	IV	+0.220	<.001	7	view →
KIRC	Male	II,III,IV	+0.144	.001	6	view →
LUSC	All	All	+0.283	<.001	5	view →
LIHC	Female	II,III,IV	+0.223	.027	5	view →
STAD	All	II,III,IV	+0.296	.011	4	view →
THCA	All	All	−0.115	.008	4	view →
READ	All	All	+0.522	.019	2	view →
CHOL	Female	All	+0.296	<.001	1	view →
KICH	All	All	+0.108	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

RN7SL146P–COAD

Open the COAD breakdown →